Efficacy trial of ingestion of the development code MSHFS001.
- Conditions
- Healthy adults
- Registration Number
- JPRN-UMIN000034056
- Lead Sponsor
- Kao Corporation
- Brief Summary
The results show that continuous intake of CGAs resulted in improvements in menopausal symptoms, especially hot flushes, in healthy women.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 82
Not provided
-Subjects who have been suffered from disease. -Subjects who regularly take medicine. -Subjects who are undergoing medical treatment or were treated by doctor within a month. -Subjects who are under hormone replacement therapy (HRT), and / or subjects who are in medication that affect blood hormone levels. -Subjects who regularly take supplements related to menopausal symptoms. -Subjects who regularly take functional food and/or supplements related to sleep. -Subjects who are pregnant, lactating, or planned to become pregnant during the test period. -Subjects with smoking habit. -Subjects who cannot follow the restriction of eating habit. -Subjects who have possibilities for emerging allergy to foods, metals, and drugs. -Subjects who are shift workers. -Subjects deemed inappropriate to participate in this study by the principle investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy of the 4 weeks ingestion of the development code MSHFS001 on menopausal symptoms and so on.
- Secondary Outcome Measures
Name Time Method